Detection Technology Oyj (HEL:DETEC)
| Market Cap | 132.49M -27.7% |
| Revenue (ttm) | 104.04M -1.3% |
| Net Income | 7.70M -21.9% |
| EPS | 0.52 -22.8% |
| Shares Out | 14.66M |
| PE Ratio | 17.39 |
| Forward PE | 13.50 |
| Dividend | 0.30 (3.32%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 15,215 |
| Average Volume | 17,548 |
| Open | 9.06 |
| Previous Close | 9.04 |
| Day's Range | 8.82 - 9.06 |
| 52-Week Range | 8.82 - 13.25 |
| Beta | 0.82 |
| RSI | 36.16 |
| Earnings Date | Apr 23, 2026 |
About Detection Technology Oyj
Detection Technology Oyj engages in the provision of X-ray detector solutions for industrial, medical, and security applications in Finland and internationally. The company offers medical computed tomography (CT) detectors; security CT detectors; photon-counting detectors; flat-panel detectors; and line scan detectors, including linear detector arrays and detectors boards. It also provides myDT+ service portfolio comprising application testing, product commissioning, customer support, repair, failure analysis, extended warranty, warehousing, an... [Read more]
Financial Performance
In 2025, Detection Technology Oyj's revenue was 101.02 million, a decrease of -6.04% compared to the previous year's 107.51 million. Earnings were 6.44 million, a decrease of -42.04%.
Financial StatementsNews
Detection Technology Oyj Earnings Call Transcript: Q4 2025
Q4 sales declined 6% year-over-year, mainly due to FX, with strong medical growth offset by declines in security and industrial. Double-digit sales growth is guided for Q1 and H1, driven by volume increases across all segments, while margins remain under pressure from product mix and competition.
Detection Technology Oyj Transcript: CMD 2025
The 2030 strategy targets 10% annual growth by expanding TFT flat panel detectors, leveraging a full in-house technology portfolio, and focusing on customer-centric innovation. Growth is expected across medical, security, and industrial markets, with a strong presence in APAC and new manufacturing in India.
Detection Technology Oyj Earnings Call Transcript: Q2 2025
Sales declined 7% in Q2, mainly due to forex and regulatory delays, but market position held firm. Industrial and medical segments grew, while security and EMEA sales dropped sharply. Outlook calls for single-digit sales decline in H2, with recovery in security expected next year.
Detection Technology Oyj Earnings Call Transcript: Q4 2024
Q4 saw modest sales growth and a strong EBITDA margin, with full-year net profit doubling and robust cash flow. Security led segment performance, while medical is expected to drive double-digit growth in Q2 2024. Price competition in China and tariff risks remain key uncertainties.
Detection Technology Oyj Earnings Call Transcript: Q2 2024
Q2 net sales grew 3.5% year-over-year to EUR 26.1 million, with EBIT margin improving to 12.7%. Security and industrial segments drove growth, while medical sales lagged due to China reforms. Double-digit growth is expected for Q3 and H2.